Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors a mechanism distinct from approved agents such as semaglutide or tirzepatide
GIP also helps with insulin release, but researchers believe that when it works in concert with GLP-1, the combination has a powerful, complementary effect on the body's overall energy balance and how it stores fat
Drinking adequate water the day of your injection keeps tissues plump and less prone to rupture
All animals were aged for at least 12 weeks before being used in their respective experiments
Some of the discourse has, candidly, veered into clickbait territory (see: Ozempic Vulva, Ozempic Earlobes), but there is actually a need for innovation around Ozempic Face, a zeitgeist-y catchall for gauntness and skin laxity that can often accompany large weight loss